Non-risk Adapted Sequential Intravesical Gemcitabine and Docetaxel for Non-muscle Invasive Bladder Cancer: The Time is Now

Journal article

Peer reviewed

Ryan L Steinberg, Michael A O'Donnell and Vignesh T Packiam

The Journal of urology, Vol.210(1), pp.5-7

07/2023

DOI: 10.1097/JU.0000000000003438

PMID: 37000006

View Online

no abstract | JU Forum

docetaxel

administration

non-muscle invasive bladder neoplasms

gemcitabine

intravesical drug

Title: Subtitle: Non-risk Adapted Sequential Intravesical Gemcitabine and Docetaxel for Non-muscle Invasive Bladder Cancer: The Time is Now
Creators: Ryan L Steinberg - University of Iowa
Michael A O'Donnell - University of Iowa
Vignesh T Packiam - University of Iowa
Resource Type: Journal article
Publication Details: The Journal of urology, Vol.210(1), pp.5-7
DOI: 10.1097/JU.0000000000003438
PMID: 37000006
NLM abbreviation: J Urol
ISSN: 0022-5347
eISSN: 1527-3792
Language: English
Electronic publication date: 03/31/2023
Date published: 07/2023
Academic Unit: Urology
Record Identifier: 9984381024402771

10 Record Views